Cite
HARVARD Citation
Tanrikulu Simsek, E. et al. (2016). Imatinib reduces bone marrow fibrosis and overwhelms the adverse prognostic impact of reticulin formation in patients with chronic myeloid leukaemia. Journal of clinical pathology. 69 (9), pp. 810-816. [Online].